UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 16

of 'Immunotherapy of non-small cell lung cancer with immune checkpoint inhibition'

16
TI
Randomized results of fixed-duration (1-yr) vs continuous nivolumab in patients (pts) with advanced non-small cell lung cancer (NSCLC)
AU
Spigel D, McLeod M, Hussein M, Waterhouse D, et al
SO
ESMO. 2017;1297O
 
AD